Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000198945 | SCV000249718 | likely benign | not provided | 2020-04-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002229027 | SCV000555953 | likely benign | HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED | 2025-01-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000198945 | SCV001247531 | uncertain significance | not provided | 2019-11-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381662 | SCV002692736 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-03-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004767135 | SCV005380623 | likely benign | not specified | 2024-08-12 | criteria provided, single submitter | clinical testing | Variant summary: CBS c.133C>T (p.Arg45Trp) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00066 in 250626 control chromosomes, including one homozygote, and predominantly at a frequency of 0.0041 within the South Asian subpopulation in the gnomAD database. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately equal to the estimated maximal expected allele frequency for a pathogenic variant in CBS causing Homocystinuria phenotype (0.003). To our knowledge, no occurrence of c.133C>T in individuals affected with Homocystinuria and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 212871). Based on the evidence outlined above, the variant was classified as likely benign. |
Natera, |
RCV001081627 | SCV001460091 | likely benign | Classic homocystinuria | 2019-12-29 | no assertion criteria provided | clinical testing |